 | • レポートコード：QYR9ST04214 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ナルコレプシー療法の世界市場について調査・分析し、ナルコレプシー療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（中枢神経系刺激薬、オキシ酸ナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他）、用途別（カタプレキシーを伴うナルコレプシー、カタプレキシーを伴わないナルコレプシー、続発性ナルコレプシー）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のナルコレプシー療法市場動向 ・主要企業別マーケットシェア ・ナルコレプシー療法の種類別市場規模2014-2019 （中枢神経系刺激薬、オキシ酸ナトリウム、選択的セロトニン再取り込み阻害薬（SSRI）、三環系抗うつ薬、その他） ・ナルコレプシー療法の用途別市場規模2014-2019 （カタプレキシーを伴うナルコレプシー、カタプレキシーを伴わないナルコレプシー、続発性ナルコレプシー） ・ナルコレプシー療法の北米市場：主要企業・種類別/用途別市場規模 ・ナルコレプシー療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ナルコレプシー療法の中国市場：主要企業・種類別/用途別市場規模 ・ナルコレプシー療法の日本国内市場：主要企業・種類別/用途別市場規模 ・ナルコレプシー療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・ナルコレプシー療法のインド市場：主要企業・種類別/用途別市場規模 ・ナルコレプシー療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Addrenex Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Ltd.、Jazz Pharmaceuticals PLC、Graymark Healthcare, Inc.、Arena Pharmaceuticals, Inc.、BIOPROJET、Shire、Ligand Pharmaceuticals, Inc.） ・ナルコレプシー療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. … These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.In 2018, the global Narcolepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Narcolepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Narcolepsy Therapeutics development in United States, Europe and China.
The key players covered in this study
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Shire
Ligand Pharmaceuticals, Inc.
Market segment by Type, the product can be split into
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Market segment by Application, split into
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Narcolepsy Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Narcolepsy Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Narcolepsy Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Central nervous system stimulants
1.4.3 Sodium Oxybate
1.4.4 Selective Serotonin Reuptake Inhibitor (SSRI)
1.4.5 Tricyclic Antidepressants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Narcolepsy Therapeutics Market Share by Application (2014-2025)
1.5.2 Narcolepsy With Cataplexy
1.5.3 Narcolepsy Without Cataplexy
1.5.4 Secondary Narcolepsy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Narcolepsy Therapeutics Market Size
2.2 Narcolepsy Therapeutics Growth Trends by Regions
2.2.1 Narcolepsy Therapeutics Market Size by Regions (2014-2025)
2.2.2 Narcolepsy Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Narcolepsy Therapeutics Market Size by Manufacturers
3.1.1 Global Narcolepsy Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Narcolepsy Therapeutics Key Players Head office and Area Served
3.3 Key Players Narcolepsy Therapeutics Product/Solution/Service
3.4 Date of Enter into Narcolepsy Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Narcolepsy Therapeutics Market Size by Type (2014-2019)
4.2 Global Narcolepsy Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Narcolepsy Therapeutics Market Size (2014-2019)
5.2 Narcolepsy Therapeutics Key Players in United States
5.3 United States Narcolepsy Therapeutics Market Size by Type
5.4 United States Narcolepsy Therapeutics Market Size by Application
6 Europe
6.1 Europe Narcolepsy Therapeutics Market Size (2014-2019)
6.2 Narcolepsy Therapeutics Key Players in Europe
6.3 Europe Narcolepsy Therapeutics Market Size by Type
6.4 Europe Narcolepsy Therapeutics Market Size by Application
7 China
7.1 China Narcolepsy Therapeutics Market Size (2014-2019)
7.2 Narcolepsy Therapeutics Key Players in China
7.3 China Narcolepsy Therapeutics Market Size by Type
7.4 China Narcolepsy Therapeutics Market Size by Application
8 Japan
8.1 Japan Narcolepsy Therapeutics Market Size (2014-2019)
8.2 Narcolepsy Therapeutics Key Players in Japan
8.3 Japan Narcolepsy Therapeutics Market Size by Type
8.4 Japan Narcolepsy Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Narcolepsy Therapeutics Market Size (2014-2019)
9.2 Narcolepsy Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Narcolepsy Therapeutics Market Size by Type
9.4 Southeast Asia Narcolepsy Therapeutics Market Size by Application
10 India
10.1 India Narcolepsy Therapeutics Market Size (2014-2019)
10.2 Narcolepsy Therapeutics Key Players in India
10.3 India Narcolepsy Therapeutics Market Size by Type
10.4 India Narcolepsy Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Narcolepsy Therapeutics Market Size (2014-2019)
11.2 Narcolepsy Therapeutics Key Players in Central & South America
11.3 Central & South America Narcolepsy Therapeutics Market Size by Type
11.4 Central & South America Narcolepsy Therapeutics Market Size by Application
12 International Players Profiles
12.1 Addrenex Pharmaceuticals, Inc.
12.1.1 Addrenex Pharmaceuticals, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Narcolepsy Therapeutics Introduction
12.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
12.2 Teva Pharmaceutical Industries Ltd.
12.2.1 Teva Pharmaceutical Industries Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Narcolepsy Therapeutics Introduction
12.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.3 Jazz Pharmaceuticals PLC
12.3.1 Jazz Pharmaceuticals PLC Company Details
12.3.2 Company Description and Business Overview
12.3.3 Narcolepsy Therapeutics Introduction
12.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.3.5 Jazz Pharmaceuticals PLC Recent Development
12.4 Graymark Healthcare, Inc.
12.4.1 Graymark Healthcare, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Narcolepsy Therapeutics Introduction
12.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.4.5 Graymark Healthcare, Inc. Recent Development
12.5 Arena Pharmaceuticals, Inc.
12.5.1 Arena Pharmaceuticals, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Narcolepsy Therapeutics Introduction
12.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.5.5 Arena Pharmaceuticals, Inc. Recent Development
12.6 BIOPROJET
12.6.1 BIOPROJET Company Details
12.6.2 Company Description and Business Overview
12.6.3 Narcolepsy Therapeutics Introduction
12.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.6.5 BIOPROJET Recent Development
12.7 Shire
12.7.1 Shire Company Details
12.7.2 Company Description and Business Overview
12.7.3 Narcolepsy Therapeutics Introduction
12.7.4 Shire Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.7.5 Shire Recent Development
12.8 Ligand Pharmaceuticals, Inc.
12.8.1 Ligand Pharmaceuticals, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Narcolepsy Therapeutics Introduction
12.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
12.8.5 Ligand Pharmaceuticals, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Narcolepsy Therapeutics Key Market Segments
Table Key Players Narcolepsy Therapeutics Covered
Table Global Narcolepsy Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Narcolepsy Therapeutics Market Size Market Share by Type 2014-2025
Figure Central nervous system stimulants Figures
Table Key Players of Central nervous system stimulants
Figure Sodium Oxybate Figures
Table Key Players of Sodium Oxybate
Figure Selective Serotonin Reuptake Inhibitor (SSRI) Figures
Table Key Players of Selective Serotonin Reuptake Inhibitor (SSRI)
Figure Tricyclic Antidepressants Figures
Table Key Players of Tricyclic Antidepressants
Figure Others Figures
Table Key Players of Others
Table Global Narcolepsy Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Narcolepsy With Cataplexy Case Studies
Figure Narcolepsy Without Cataplexy Case Studies
Figure Secondary Narcolepsy Case Studies
Figure Narcolepsy Therapeutics Report Years Considered
Table Global Narcolepsy Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Narcolepsy Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Narcolepsy Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Narcolepsy Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Narcolepsy Therapeutics Market Share by Regions 2014-2019
Figure Global Narcolepsy Therapeutics Market Share by Regions 2014-2019
Figure Global Narcolepsy Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Narcolepsy Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Narcolepsy Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Narcolepsy Therapeutics Market Share by Manufacturers in 2018
Table Global Narcolepsy Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Narcolepsy Therapeutics Product/Solution/Service
Table Date of Enter into Narcolepsy Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Narcolepsy Therapeutics Market Size Share by Type (2014-2019)
Figure Global Narcolepsy Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Narcolepsy Therapeutics Market Size Share by Application (2014-2019)
Figure Global Narcolepsy Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Narcolepsy Therapeutics Revenue Market Share by Application in 2018
Figure United States Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table United States Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table United States Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Narcolepsy Therapeutics Market Share by Application (2014-2019)
Figure Europe Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table Europe Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table Europe Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Narcolepsy Therapeutics Market Share by Application (2014-2019)
Figure China Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table China Narcolepsy Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table China Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Narcolepsy Therapeutics Market Share by Application (2014-2019)
Figure Japan Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table Japan Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table Japan Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Narcolepsy Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table Southeast Asia Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Narcolepsy Therapeutics Market Share by Application (2014-2019)
Figure India Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table India Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table India Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Narcolepsy Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Narcolepsy Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Narcolepsy Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Narcolepsy Therapeutics Market Share (2018-2019)
Table Central & South America Narcolepsy Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Narcolepsy Therapeutics Market Share by Type (2014-2019)
Table Central & South America Narcolepsy Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Narcolepsy Therapeutics Market Share by Application (2014-2019)
Table Addrenex Pharmaceuticals, Inc. Company Details
Table Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019) (Million US$)
Figure Addrenex Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Addrenex Pharmaceuticals, Inc. Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Jazz Pharmaceuticals PLC Company Details
Table Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure Jazz Pharmaceuticals PLC Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Jazz Pharmaceuticals PLC Recent Development
Table Graymark Healthcare, Inc. Company Details
Table Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure Graymark Healthcare, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Graymark Healthcare, Inc. Recent Development
Table Arena Pharmaceuticals, Inc. Company Details
Table Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure Arena Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Arena Pharmaceuticals, Inc. Recent Development
Table BIOPROJET Company Details
Table BIOPROJET Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure BIOPROJET Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table BIOPROJET Recent Development
Table Shire Company Details
Table Shire Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Shire Recent Development
Table Ligand Pharmaceuticals, Inc. Company Details
Table Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)(Million US$)
Figure Ligand Pharmaceuticals, Inc. Revenue Growth Rate in Narcolepsy Therapeutics Business (2014-2019)
Table Ligand Pharmaceuticals, Inc. Recent Development
Table Global Narcolepsy Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Narcolepsy Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Narcolepsy Therapeutics Market Size Share by Regions in 2025
Figure United States Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Narcolepsy Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Narcolepsy Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Narcolepsy Therapeutics Market Size by Product (2019-2025)
Figure Global Narcolepsy Therapeutics Market Size by Product in 2025
Table Global Narcolepsy Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Narcolepsy Therapeutics Market Size by Application (2019-2025)
Figure Global Narcolepsy Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
中枢神経系疾患治療法の世界市場：市場規模・現状・予測 Central Nervous System (CNS) disorders are also called as neurological and psychiatric disorders. CNS disorders can affect either the brain or spinal cord, or both. Depression is the dominated market of CNS Disorders Therapeutics In 2018, the global Central Nervous System Disorders Therapeutics mark…- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- うつ病用治療の世界市場：インサイト・予測 Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and beh…
- 双極性障害の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…
- 術後疼痛治療サービスの世界市場：市場規模・現状・予測 More than 75% of patients undergoing surgery suffer from acute pain. Postoperative pain is defined as a condition of tissue injury together with muscle spasm after surgery. Recently, peripheral and central sensitization has been shown within the mechanisms of postoperative pain generation.In 2018, t…